openPR Logo
Press release

BOC Sciences Improves Its Fermentation CDMO Platform for Microbial Drug Development

11-29-2021 09:26 AM CET | Health & Medicine

Press release from: BOC Sciences

BOC Sciences, a provider of CDMO services for the development of microbial drugs, recently announced that it has improved its fermentation CDMO platform to provide a comprehensive one-stop industrial fermentation CDMO service.

In the field of biotechnology, fermentation refers to any process in which microbes multiply rapidly to produce a variety of valuable compounds. Bacteria (such as E. coli, the most commonly used microorganism in microbial fermentation), algae, fungus, and actinomycetes are among the microorganisms utilized in biotechnological fermentation and enzyme synthesis. BOC Sciences provides seamless one-stop process development services from concept to commercialization, which can help clients promote their project management and meet their project schedules.

Workflow of BOC Sciences' fermentation CDMO service platform
1. Strain selection and optimization
The selected strains need to meet the following conditions:
Support the large-scale production of the required microbial products
Fast growth rate and safe operation
Compatible with media
Low production cost
Conducive to isolation procedures in the fermentation process
Stable and easy to genetic manipulation
After strain selection, strain optimization can be achieved through mutation and selection processes.

2. Media and process development
The culture medium needs to meet the following criteria:
Maximum production capacity of the required product
Allows integrated fermentation process development and manufacturing to run at the highest possible speed
Produces very small amounts of unwanted by-products.
Consistent quality
After the selection of the medium, the fermentation process needs to be integrated and developed to determine the GMP manufacturing route of the microbial drugs from the early stage to the clinical and commercial supply.

3. Fermentation and scale-up
Large-scale fermentation can be achieved through three methods: batch culture fermentation, fed-batch fermentation, and continuous fermentation.

4. Downstream processing
BOC Sciences provides an extensive collection of downstream processing services, including microfiltration, centrifugation, liquid/liquid extraction, ultrafiltration, evaporation, and packaging.

Highlights of BOC Sciences' Fermentation CDMO Platform
Full-service package from intermediate to API, from fermentation to synthesis, and from small molecule drugs to macromolecules.
Flexible production capabilities and qualified personnel, as well as supporting operations such as QA, Analytics, and EHS.
State-of-the-art facilities cover various products like cytotoxic and sterile products.
Investment in environmental protection measures and skills.
Well-established quality system that has passed a series of official inspections and customer audits.

For more detailed information about the fermentation CDMO service of BOC Sciences, please visit the website: https://bio-fermen.bocsci.com.

About BOC Sciences
BOC Sciences seeks to assist researchers in the sectors of food safety, life sciences, and pharmaceuticals with its professional and high-quality microbial metabolite products and services. Antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other compounds fermented and separated from actinomycetes, bacteria, fungi, plants, and other organisms are all included in BOC Sciences' product catalog. Its ambition is to become the world's most competitive and productive metabolite provider.

BOC Sciences
Shirley, NY 11967, USA
account@bocsci.com

BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BOC Sciences Improves Its Fermentation CDMO Platform for Microbial Drug Development here

News-ID: 2477004 • Views:

More Releases from BOC Sciences

Prof. Gang Zheng to Share Insights on Theranostic Lipid Nanoparticles in Exclusi …
BOC Sciences hosts Prof. Gang Zheng in a groundbreaking webinar on theranostic lipid nanoparticles for cancer medicine. BOC Sciences announces an upcoming webinar featuring Prof. Gang Zheng, a senior scientist in nanomedicine and cancer theranostics. The webinar, titled "Theranostic Lipid Nanoparticles for Cancer Medicine," will take place this July, offering researchers and industry professionals cutting-edge insights into the development and application of lipid nanoparticles for combined therapy and diagnostics. Event Details Date: July
BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate
BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its well-established conjugation platform, BOC Sciences supports pharmaceutical and biotechnology clients at the forefront of drug conjugation. Peptide-drug conjugates (PDCs) are mainly used in anti-cancer therapy, which integrates the advantages of small molecular weight, high tumor penetration, low immunogenicity, large-scale synthesis using solid phase synthesis, low
BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Part …
In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands. Innovations in manufacturing processes, more complicated formulations, and increasingly complex global supply chains are just some of the factors making it more difficult for companies to assess and control impurities in drug substances and drug products. BOC Sciences is confident to employ
High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Hea …
New York, United States-Oct 12, 2022-Managing raw materials as part of the quality system will ensure that all finished healthcare products can meet quality attributes. As a comprehensive supplier of CRO/CMO/CDMO fermentation services, BOC Sciences is able to provide clients with high-standard raw materials to ensure quality attributes of final healthcare products. Some key factors that should be taken into consideration when selecting raw materials for healthcare products include sufficient

All 4 Releases


More Releases for CDMO

Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications. The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for